Finance

Remembering Fred Frank, Lisa Raines, plus CRISPR, Washington updates

Deal in Focus: An mRNA partnership between Chinese in-licensing play Everest Medicines and Canadian biotech Providence Therapeutics

On the latest BioCentury This Week podcast, BioCentury’s editors remember Fred Frank and Lisa Raines, two remarkable leaders who helped make the biopharma industry what it is today. They also deliver an update on the latest from Washington and the CRISPR translational space as well as this week’s Deal in Focus, an mRNA partnership between Chinese in-licensing play Everest Medicines Ltd. (HKEX:1952) and Canadian biotech Providence Therapeutics.